We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Woodcock Details Proposals to Spur Drug Competition and Curb Misuse
Woodcock Details Proposals to Spur Drug Competition and Curb Misuse
CDER Director Janet Woodcock flagged proposals in the FDA’s fiscal year 2020 budget designed to encourage drug competition and seal regulatory loopholes in testimony before a Senate drug pricing hearing on Wednesday.